Gemtesa 75 MG tablet 30S
Ended Awarded
- Contract number
- SPE2DB25FRCTZ
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $4,233
Award facts
- Contract value 100% obligated
- $4,232.99 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $4,232.99 to AmerisourceBergen Drug Corp for the supply of Gemtesa 75 mg tablets (30-count) on July 29, 2025, with an ultimate completion date of July 30, 2025. This firm fixed-price delivery order represents a non-set-aside competitive award to the pharmaceutical distributor's Corporate Office located in Conshohocken, Pennsylvania. The award falls under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026, which serves as a comprehensive global pharmaceutical support vehicle enabling the company to supply medications and medical supplies to support military healthcare programs worldwide.
AmerisourceBergen Drug Corp is a major pharmaceutical distributor and critical federal medical procurement vendor that supplies brand-name and generic medications, vaccines, medical devices, and specialized healthcare commodities across multiple therapeutic domains to the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. The company's extensive federal contract portfolio with DLA demonstrates its capability to fulfill competitively awarded delivery orders on a routine basis, ranging from small-value transactions to substantial orders exceeding $45,000. This particular delivery order for Gemtesa, a medication used in urological treatment, exemplifies the company's role in providing specialized pharmaceuticals to support military and federal healthcare operations.
Quick answers
Who was awarded contract SPE2DB25FRCTZ?
SPE2DB25FRCTZ was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on July 29, 2025.
How much is contract SPE2DB25FRCTZ worth?
The government has obligated $4,233 on SPE2DB25FRCTZ.
Is contract SPE2DB25FRCTZ an order under another contract?
Yes. SPE2DB25FRCTZ is a delivery order under SPE2DB25D3008, an indefinite delivery contract.
Was contract SPE2DB25FRCTZ competed?
The extent of competition for SPE2DB25FRCTZ was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award